Highlights Bio-Thera Solutions, Ltd.

Equities

688177

CNE100003R98

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 16/05/2024 BST			5-day change	1st Jan Change
30.12 ^CNY	+2.80%		-8.45%	-26.96%

05-10	China Grants Clinical Trial Approval to Bio-Thera's Anti-Tumor Combination Therapy	MT
04-29	Bio-Thera Solutions, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China Grants Clinical Trial Approval to Bio-Thera's Anti-Tumor Combination Therapy	05-10	MT
Bio-Thera Solutions, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Bio-Thera Solutions Receives IND Clearance From US FDA to Initiate a Phase II Study for BAT8006	03-25	CI
Bio-Thera Solutions Grants Marketing Rights of Two Drugs to Latin American Company	03-20	MT
Bio-Thera Solutions, Ltd. Partners with SteinCares to Market Two Biosimilars in LATAM	03-18	CI
Bio-Thera Solutions, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02-23	CI
Bio-Thera Solutions Announces Initiation of Phase IB / IIA Clinical Trial for BAT6026	02-01	CI
Bio-Thera Solutions Gets Regulatory Nod for Trial of Tumor Drug Combination Treatment	01-12	MT
Bio-Thera Solutions Wins US FDA Nod to Market Cancer Drug	12-08	MT
FDA Approves Bio-Thera Solutions' Avzivi (Bevacizumab-Tnjn), A Biosimilar Referencing Avastin	12-07	CI
Bio-Thera Solutions Announces Positive Results from Phase 3 Study of BAT2206, a Proposed Biosimilar Referencing Stelara	11-29	CI
Bio-Thera Solutions, Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Chugai Parent Roche Settles US Lawsuit Against Biogen Over Alleged Biosimilar Infringement	24/10/23	MT
Roche, Biogen Settle US Patent Infringement Case Over Actemra Biosimilar	24/10/23	MT
Roche settles US patent lawsuit against Biogen over blockbuster arthritis drug	23/10/23	RE
FDA Approves Bio-Thera Solutions, Ltd.'s Partner Biogen Receives Notification from the United States Food and Drug Administration	08/10/23	CI
Biogen Says US FDA Approves Tocilizumab Biosimilar Tofidence	29/09/23	MT
Bio-Thera Solutions, Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23	CI
Bio-Thera Solutions, Ltd. Announces Positive Phase 1 Clinical Data for Bat8006 (Folate-Receptor-A-Adc) and Presents Phase 1 Dose Escalation Study At the Bethune Obstetrics and Gynecology Forum	12/08/23	CI
Chugai Pharmaceutical Files Patent Infringement Lawsuit Against Biogen, Bio-Thera	18/07/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Bio-Thera Solutions, Ltd.

Equities

688177

CNE100003R98

Highlights

Filters